All In Biotech

Free tool

FAERS Monitor: Thalomid

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021430 or its brand name (Thalomid, Thalidomide). Reports on generic versions are filed under their own applications.

Reports

36,691

Serious

32,479

89% of reports

Hospitalization

10,666

Death reported

12,186

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • death6,421
  • disease progression2,495
  • plasma cell myeloma2,058
  • off label use1,842
  • neuropathy peripheral1,829
  • pneumonia1,716
  • fatigue1,418
  • drug ineffective1,169
  • anaemia1,026
  • asthenia1,024
  • constipation1,001
  • dyspnoea995
  • pyrexia961
  • thrombocytopenia884
  • nausea868

Reports by year received

View as table
YearReports
20044,416
20054,279
2006809
2007769
20082,021
2009983
2010900
2011951
2012956
20131,128
20141,621
20152,888
20161,716
20171,464
20181,456
20191,520
20201,487
20211,447
20221,635
20231,454
20241,182
20251,009
2026600

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,017,468 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
plasma cell myelomaSignal2,05831.930.558,362
disease progressionSignal2,49512.311.925,552
neuropathy peripheralSignal1,82911.210.716,762
thrombocytopeniaSignal8844.64.32,447
deathSignal6,4214.34.216,808
anaemiaSignal1,0263.12.91,458
pneumoniaSignal1,7163.02.92,385
constipationSignal1,0012.62.51,023
pyrexia9611.61.5215
asthenia1,0241.61.5210
off label use1,8421.21.267
fatigue1,4181.01.03
dyspnoea9951.00.90
nausea8680.60.6198
drug ineffective1,1690.50.5593

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.